Cardiovascular Risk

Heart health
, well managed

Blood pressure, cholesterol, and cardiovascular risk reduction — physician-led virtual care for primary and secondary prevention.

Book a Consultation How It Works

Within 1–2 weeksInternist-ledVirtual across Ontario

50%Reduction in CV events with optimised therapy

Internist-Led

Specialist medical oversight

≈ 1–2 Weeks

Typical first appointment

Lipid Optimisation

Modern therapy combinations

BP Targets

Evidence-based, individualised

100% Virtual

Home BP monitoring supported

About This Program

Prevent the heart attack you do not want

Cardiovascular risk management — hypertension treatment, cholesterol optimisation, and primary/secondary prevention of heart disease. Led by internists with cardiovascular and metabolic expertise.

Cardiovascular disease is the most preventable major cause of death — yet most people are undertreated. Adequate blood pressure control, modern lipid therapy, and lifestyle work — applied consistently over years — change outcomes.

Most cardiovascular events (heart attacks, strokes) are preventable with the right combination of blood pressure control, cholesterol management, lifestyle, and modern preventive medications. Our program helps you build that protection — virtually, evidence-based, with regular monitoring.

Conditions Treated

Who we help

Our heart health program supports patients with:

Hypertension (resistant or new-onset)

High cholesterol / dyslipidemia

Metabolic syndrome

Family history of heart disease

Post-MI / post-stroke optimisation

Atrial fibrillation co-management

Lipoprotein(a) elevation

Inflammatory cardiovascular risk

Pre-diabetes with cardiovascular risk

Smoking cessation support

Statin intolerance workup

Chronic kidney disease + CV risk

Treatment Options

Modern cardiovascular therapies

Following physician assessment and lab review, your program may include:

Foundation

Rosuvastatin / Atorvastatin

High-Intensity Statin

Foundational therapy for cardiovascular risk reduction. Properly dosed, statins reduce heart attack and stroke risk by 25–50%. Modern protocols target LDL <2.0 mmol/L for high-risk patients.

Lipid-Lowering

Ezetimibe

LDL-Lowering Add-On

Used alongside statins when LDL targets are not met. Generic, well-tolerated, and adds 15–25% LDL reduction.

Lipid-Lowering

PCSK9 Inhibitors

Repatha, Praluent

Injectable LDL-lowering for patients with very high CV risk or statin intolerance. Reduces LDL by 50–60%.

Advanced Lipid Therapy

BP Therapy Combinations

ACE/ARB + CCB + Diuretic

Most BP control requires 2–3 medications. Modern combination tablets simplify daily dosing while reaching target BPs.

Antihypertensive

Our Process

How your program works

A clear pathway from inquiry to optimised cardiovascular protection.

Initial Intake & Records Review

Send recent labs (lipid panel, A1C, kidney function, etc.), home BP readings if available, and current medications. Our team reviews within one business day.

Lab Work if Needed

Updated lipid panel including non-HDL and ApoB, kidney function, glucose, and (where indicated) Lp(a) and inflammatory markers.

Specialist Consultation

A virtual consult with your DOS physician to review your full cardiovascular risk profile and design a personalised plan.

Therapy Optimisation

Prescriptions for BP and lipid medications, lifestyle counselling, and (where indicated) home BP monitoring guidance.

Ongoing Follow-Up

Every 3–6 months for monitoring — checking that BP and lipid targets are met, adjusting therapy, and re-assessing CV risk over time.

Eligibility

Is this program right for you?

Our cardiovascular risk program is open to most adults with risk factors or established disease.

You may be a good candidate if you:

Have hypertension (treated or newly diagnosed)

Have high cholesterol or family history

Have had a heart attack, stroke, or stent

Have diabetes with CV risk

Have metabolic syndrome

Are an Ontario resident with a valid health card

This program may not be suitable if you:

Are experiencing acute chest pain (call 911)

Have unstable angina or recent ACS (cardiology care)

Need urgent in-person cardiology evaluation

Program Physician

Program Lead

Dr. Mitra Mahdavi-Mazdeh

MD, FRCPC

Internal Medicine, Nephrology, and Women's Health specialist with 20+ years of experience and Royal College certification.

Internal Medicine, Nephrology, Women's Health

View full profile →

Build the heart you want for the next 30 years

Specialist-led cardiovascular risk reduction — typically within 1–2 weeks. Modern therapy, evidence-based targets, ongoing monitoring.

Book as a Patient

Self-refer via our secure online booking system

Refer a Patient

Physician referral form with fax & secure intake

Frequently Asked Questions

Heart health FAQ

Common questions about cardiovascular risk reduction.

My family doctor manages my BP — why see another physician?

Many family doctors do an excellent job. But cardiovascular risk reduction has evolved rapidly — ApoB, Lp(a), modern targets, newer therapies (PCSK9 inhibitors, bempedoic acid, etc.). Our program acts as specialist input, with your family doctor staying primary on day-to-day care.

I have heard statins are bad for you — is that true?

No. Statins are among the most studied medications in history, with overwhelming evidence of cardiovascular benefit. Side effects are real but uncommon, and usually manageable with dose changes or switches. Your physician will discuss your individual risk-benefit.

Why is my LDL target so low?

Modern guidelines target LDL <2.0 mmol/L for most patients with established cardiovascular disease, diabetes with risk factors, or very high family risk. Lower LDL = lower event rates. The "normal" lab reference range is NOT the same as your individual treatment target.

Can I monitor my BP at home?

Yes — and we recommend it. Home BP readings are often more accurate than office readings (no white-coat effect). Your physician will guide proper technique and target values.

I had a stent put in — can you manage my prevention going forward?

Absolutely. Secondary prevention (after a heart attack, stent, or stroke) is high-priority and benefits enormously from regular specialist input. We coordinate with your cardiologist for procedural follow-up while we optimise your medical therapy.

Will I need to be on these medications forever?

For most patients with elevated cardiovascular risk: yes, lifelong therapy is the model — because the risk does not go away. The good news is modern medications are well tolerated and dramatically reduce events when taken consistently.

Heart health, well managed